199 related articles for article (PubMed ID: 18377776)
1. Hypersensitivity reactions to oxaliplatin and other antineoplastic agents.
Syrigou E; Syrigos K; Saif MW
Curr Allergy Asthma Rep; 2008 Mar; 8(1):56-62. PubMed ID: 18377776
[TBL] [Abstract][Full Text] [Related]
2. Hypersensitivity reactions associated with oxaliplatin.
Saif MW
Expert Opin Drug Saf; 2006 Sep; 5(5):687-94. PubMed ID: 16907658
[TBL] [Abstract][Full Text] [Related]
3. Fever as the only manifestation of hypersensitivity reactions associated with oxaliplatin in a patient with colorectal cancer Oxaliplatin-induced hypersensitivity reaction.
Saif M; Roy S; Ledbetter L; Madison J; Syrigos K
World J Gastroenterol; 2007 Oct; 13(39):5277-81. PubMed ID: 17876901
[TBL] [Abstract][Full Text] [Related]
4. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol.
Gammon D; Bhargava P; McCormick MJ
Oncologist; 2004; 9(5):546-9. PubMed ID: 15477639
[TBL] [Abstract][Full Text] [Related]
5. Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule.
Meyer L; Zuberbier T; Worm M; Oettle H; Riess H
J Clin Oncol; 2002 Feb; 20(4):1146-7. PubMed ID: 11844841
[No Abstract] [Full Text] [Related]
6. Desensitizing oxaliplatin-induced fever: a case report.
Madrigal-Burgaleta R; Berges-Gimeno MP; Angel-Pereira D; Guillen-Ponce C; Sanz ML; Alvarez-Cuesta E
J Investig Allergol Clin Immunol; 2013; 23(6):435-6. PubMed ID: 24459821
[No Abstract] [Full Text] [Related]
7. Hypersensitivity Reactions to oxaliplatin: incidence and management.
Gowda A; Goel R; Berdzik J; Leichman CG; Javle M
Oncology (Williston Park); 2004 Nov; 18(13):1671-5; discussion 1676, 1680, 1683-4. PubMed ID: 15648298
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
Wong JT; Ling M; Patil S; Banerji A; Long A
J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
[TBL] [Abstract][Full Text] [Related]
9. Hypersensitivity Reactions to Oxaliplatin: Identifying the Risk Factors and Judging the Efficacy of a Desensitization Protocol.
Okayama T; Ishikawa T; Sugatani K; Yoshida N; Kokura S; Matsuda K; Tsukamoto S; Ihara N; Kuriu Y; Nakanishi M; Nakamura T; Kamada K; Katada K; Uchiyama K; Takagi T; Handa O; Konishi H; Yagi N; Naito Y; Otsuji E; Hosoi H; Miki T; Itoh Y
Clin Ther; 2015 Jun; 37(6):1259-69. PubMed ID: 25862137
[TBL] [Abstract][Full Text] [Related]
10. Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol.
Syrigou EI; Karapanagiotou EM; Alamara CV; Boura PG; Saif MW; Syrigos KN
Clin Colorectal Cancer; 2009 Apr; 8(2):106-9. PubMed ID: 19739272
[TBL] [Abstract][Full Text] [Related]
11. Clinical Features of Oxaliplatin Induced Hypersensitivity Reactions and Therapeutic Approaches.
Bano N; Najam R; Qazi F; Mateen A
Asian Pac J Cancer Prev; 2016; 17(4):1637-41. PubMed ID: 27221832
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Prolonged Infusion on Reducing Oxaliplatin Hypersensitivity Reactions.
Zhang X; Zhao Y; Zheng Y; Dong Y
J Investig Allergol Clin Immunol; 2017; 27(1):65-66. PubMed ID: 28211349
[No Abstract] [Full Text] [Related]
13. Hypersensitivity reactions to oxaliplatin: what nurses need to know.
Bonosky K; Miller R
Clin J Oncol Nurs; 2005 Jun; 9(3):325-30. PubMed ID: 15973843
[TBL] [Abstract][Full Text] [Related]
14. Hypersensitivity reactions associated with oxaliplatin and their clinical management.
Toki MI; Saif MW; Syrigos KN
Expert Opin Drug Saf; 2014 Nov; 13(11):1545-54. PubMed ID: 25307143
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin-associated hypersensitivity reactions: clinical presentation and management.
Hewitt MR; Sun W
Clin Colorectal Cancer; 2006 Jul; 6(2):114-7. PubMed ID: 16945166
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.
Polyzos A; Tsavaris N; Gogas H; Souglakos J; Vambakas L; Vardakas N; Polyzos K; Tsigris C; Mantas D; Papachristodoulou A; Nikiteas N; Karavokyros JG; Felekouras E; Griniatsos J; Giannopoulos A; Kouraklis G
Oncology; 2009; 76(1):36-41. PubMed ID: 19033714
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of reintroducing oxaliplatin to patients with colorectal cancer after mild hypersensitivity reactions.
Park SJ; Lee KY; Park WS; Min SY
Oncology; 2013; 85(6):323-7. PubMed ID: 24247529
[TBL] [Abstract][Full Text] [Related]
18. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment.
Madrigal-Burgaleta R; Berges-Gimeno MP; Angel-Pereira D; Ferreiro-Monteagudo R; Guillen-Ponce C; Pueyo C; Gomez de Salazar E; Alvarez-Cuesta E
Allergy; 2013 Jul; 68(7):853-61. PubMed ID: 23647576
[TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity and idiosyncratic reactions to oxaliplatin.
Thomas RR; Quinn MG; Schuler B; Grem JL
Cancer; 2003 May; 97(9):2301-7. PubMed ID: 12712487
[TBL] [Abstract][Full Text] [Related]
20. Hypersensitivity reactions to oxaliplatin: experience in a single institute.
Siu SW; Chan RT; Au GK
Ann Oncol; 2006 Feb; 17(2):259-61. PubMed ID: 16282245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]